Tumor Ablation Market Size, Share & Trends Report

Tumor Ablation Market Size, Share & Trends Analysis Report By Treatment (Surgical, Laparoscopic), By Technology (Radiofrequency, Microwave, Cryoablation), By Application, And Segment Forecasts, 2018 - 2025

  • Published Date: Aug, 2018
  • Base Year for Estimate: 2017
  • Report ID: 978-1-68038-746-9
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 92

Industry Insights

The global tumor ablation market size was estimated at USD 933.5 million in 2017 and is expected to expand at CAGR of 11.12% over the forecast period. Increasing prevalence of cancer is the major factor contributing to market growth. Based on the statistics published by the World Health Organization (WHO), about 13% of global population suffers from cancer each year. In addition, 70.0% rise is expected in cancer cases over the next few decades. More than 100 types of cancer require tumor ablation. This factor is anticipated to boost demand over the forecast period.

North America tumor ablation market

Technological advancements in thermal ablation technology are anticipated to fuel demand for these procedures. Aging population in the world is expected to double in near future. According to statistics provided by the WHO, proportion of global population over 60 years is likely to double from 12% to 22% between 2015 and 2050.

Increasing geriatric population is driving demand for minimally invasive surgeries (MIS). These surgeries cause less trauma and faster recovery, compared to invasive procedures. Therefore, demand for minimally invasive procedures such as radiofrequency ablation is on the rise. This factor is anticipated to drive global market in the forthcoming years.

Extensive adoption of minimally invasive procedures owing to their benefits such as speedy recovery, less trauma, and minimal complications is anticipated to boost demand for tumor ablation technologies. Active efforts from healthcare agencies and governments to create awareness about various types of cancer is expected to further boost the demand for this therapy.

Rising demand for laser ablation, irreversible electroporation, and High Intensity Focused Ultrasound (HIFU) is anticipated to propel market growth over the forecast period. Increasing per capita income is also anticipated to further drive growth. Rising per capita income in developed as well as developing nations is encouraging people to opt for advanced therapies, thus assisting market growth.

Technology Insights

On the basis of technology, the market has been segmented into microwave, radiofrequency, cryoablation, and other technologies such as radio iodine, HIFU, and laser ablation. Radiofrequency held substantial market share in 2017. This technology makes use of imaging devices and needle electrode probe to pierce through skin. High frequency currents are passed through electrode for generating heat to destroy cyst. Radiofrequency electric currents generate sound waves. These waves then generate heat reacting target cell molecule. Prominent application in solid tumor removal is expected to bode well for segment growth in the forthcoming years. Rising usage in solid tumor excision is a prime factor responsible for the lucrative market growth. Moreover, efficiency and specificity of this method is anticipated to further contributed to its adoption.

Microwave ablation is anticipated to witness remunerative growth over the forecast period owing to various benefits offered by this technology. It utilizes electromagnetic methods for destruction of cysts with the help of device frequencies of at least 900 MHz. This technology is advantageous over other techniques, in terms of effectiveness. Benefits include larger tumor ablation volume, consistency at high temperature, lesser removal time, reduced procedural pain, and optimal heating of cystic mass. Minimum procedure time for this technology is of 5 to 10 minutes. Improved efficacy with reduced complications and hospital stay are expected to drive growth over the forecast period.

Treatment Insights

On the basis of treatment, the tumor ablation market has been segmented into surgical, laparoscopic, and percutaneous procedures. The surgical segment held substantial share of 42.1% in 2015. Increased prevalence of liver and breast cancer, both of which require open surgical procedures, contributed to growth of this segment.

On the other hand, percutaneous ablation is anticipated to be the fastest growing segment over the forecast period. This procedure involves treating tumors through skin. In this advanced method, a small incision is made on skin through which radiofrequency probe is inserted. This probe terminates the cyst in target tissues. Rising demand for minimally invasive surgeries, quick procedure and recovery time, and decreased scarring and patient comfort are high-impact rendering factors for growth of this segment.

Application Insights

On the basis of application, the market is segmented into liver, breast, lung, prostate, and other types of cancer. The other segment includes bone metastasis, kidney cancer, and ENT cancer. High prevalence and availability of advanced methods are anticipated to assist market expansion over the forecast period. Liver cancer accounted for the largest market share in 2015. This is most prominent type of cancer among males than females. Rising incidence of bile duct cancer and primary liver cancer are anticipated to further boost growth in near future.

Lung cancer segment is anticipated to expand at the highest CAGR during the forecast period. Rising prevalence of Non-Small Cell Lung Cancer (NSCLC) is expected to propel demand in the forthcoming years. NSCLC utilizes radiofrequency ablation prominently, use of needle or probe till it reaches target cells, and destruction of tumor cells by generating heat is the basic methodology involved. Local anesthesia is administered sometimes when it is excessive trauma is expected.

Regional Insights

North America emerged as the dominant regional segment with over 34.0% market share in 2017. Government support for quality healthcare, high Purchasing Power Parity (PPP), flexible reimbursement policies, and high prevalence of cancers are the primary regional drivers. In U.S., the Patient Protection and Affordable Care Act (PPACA), also known as ObamaCare, promotes quality and affordability of health insurance and reduces healthcare cost for individual and government. In addition, precision medicine initiative is formulating tailored strategies based on unique disease characteristics. Such initiatives are helping to improve healthcare system in North America. This factor is anticipated to bode well for regional market growth.

Global America tumor ablation market

Europe accounted for about 24.0% market share in 2017. Greater extent of public funding in the regional healthcare system has contributed to this growth. Moreover, growing geriatric population coupled with government support to control cancer are anticipated to lead to substantial growth of this region. Formation of bodies, such as the European Cancer Observatory to spread awareness regarding cancer is anticipated to further propel regional expansion in the forthcoming years. 

Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare infrastructure owing to government initiatives. Moreover, economic developments in countries such as India and China are expected to help regional growth. Huge population base with low per capita income is leading to high demand for affordable treatment options. Multinational companies are looking to invest in India and China. Thus, many collaborative partnerships and strategic alliances are anticipated to take place in this region.

Tumor Ablation Market Share Insights

Key market players are Galil Medical Inc.; Misonix Inc.; HealthTronics; Angiodynamics, Boston Scientific Corporation; Medtronic Plc. (Covidien); SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical Inc. These players have adopted various strategies such as new product launches, collaborations, technological advancements, and mergers and acquisitions to maintain their market positions.

In a recent development, Covidien Plc acquired BARRX Medical Inc. leading to rights of Medtronic on Barrx Flex RFA System and other bipolar RF ablation devices. In another instance, Galil Medical Inc. recently launched a new family of cryoablation needles, IcePearl 2.1 CX, IceFORCE 2.1CX. This launch is expected to strengthen the company’s product portfolio.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2016

Forecast period

2018 - 2025

Market representation

Revenue in USD Million & CAGR from 2018 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, & MEA

Country scope

U.S., Canada, U.K., Germany, France, Italy, Spain, Switzerland, Poland, Belgium, Japan, China, Brazil, Mexico, and South Africa

Report coverage

Revenue, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the global tumor ablation market report on the basis of technology, treatment, application, and region:

  • Technology Outlook (Revenue, USD Million, 2014 - 2025)

    • Radiofrequency

    • Microwave

    • Cryoablation

    • Irreversible Electroporation

    • Others

  • Treatment Outlook (Revenue, USD Million, 2014 - 2025)

    • Surgical

    • Laparoscopic

    • Percutaneous

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Liver Cancer

    • Breast Cancer

    • Lung Cancer

    • Prostate Cancer

    • Other Cancer

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Belgium

      • Switzerland

      • Poland

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East and Africa (MEA)

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $7,950
Compass Access - $9,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified